Metamizole-induced agranulocytosis: utilisation trends, pharmacovigilance signals and regulatory risk-minimisation in Switzerland. Swiss Medical Weekly, [S. l.], v. 156, n. 6, p. 5062, 2026. DOI: 10.57187/5062. Disponível em: https://smw.ch/index.php/smw/article/view/5062. Acesso em: 25 jul. 2026.